Anabel Sánchez-Martín
Universidad de Salamanca(ES)Instituto de Investigación Biomédica de Salamanca(ES)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Mechanisms and Therapy, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Molecular Bases of Drug Resistance in Hepatocellular Carcinoma(2020)194 cited
- → Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma(2020)60 cited
- → A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma(2020)32 cited
- → Role of Genetic Variations in the Hepatic Handling of Drugs(2020)25 cited
- → Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems(2021)15 cited
- → Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib(2018)13 cited
- → eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma(2023)12 cited
- → Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells(2023)11 cited
- → Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma(2019)8 cited
- → Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs(2023)7 cited